Psychotropic medication and the heart

Psychotropic literature in recent years has become very concerned with the cardiac safety of certain psychotropic medication. This paper reviews some of the cardiac factors to be considered in the safer selection of psychotropic drugs for the vulnerable patient in everyday clinical practice.

[1]  R. Califf,et al.  Sertraline treatment of major depression in patients with acute MI or unstable angina , 2002, European Neuropsychopharmacology.

[2]  M. Arima,et al.  Serum levels of eosinophil cationic protein in patients with eosinophilic myocarditis. , 2002, International journal of cardiology.

[3]  S. Valenzuela,et al.  Clozapine and sudden death. , 2001, Journal of clinical psychopharmacology.

[4]  B. Penninx,et al.  Depression and cardiac mortality: results from a community-based longitudinal study. , 2001, Archives of general psychiatry.

[5]  M. Kotler,et al.  Reversal of Pathologic Cardiac Parameters after Transition from Clozapine to Olanzapine Treatment: A Case Report , 2001, Clinical neuropharmacology.

[6]  Marcus W. Agelink,et al.  Effects of Newer Atypical Antipsychotics on Autonomic Neurocardiac Function: A Comparison Between Amisulpride, Olanzapine, Sertindole, and Clozapine , 2001, Journal of clinical psychopharmacology.

[7]  S. Ramsay.  UK government looks to expand research on embryos , 2000, The Lancet.

[8]  J. Gorman,et al.  Heart rate variability in depressive and anxiety disorders. , 2000, American heart journal.

[9]  C. Nemeroff,et al.  Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. , 2000, Archives of general psychiatry.

[10]  J. Idle.  The heart of psychotropic drug therapy , 2000, The Lancet.

[11]  J. Tamargo.  Drug-induced torsade de pointes: from molecular biology to bedside. , 2000, Japanese journal of pharmacology.

[12]  S. Ayis,et al.  QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients , 2000, The Lancet.

[13]  N. Chan.  Clozapine and sudden death , 2000, The Lancet.

[14]  D. Celermajer,et al.  Myocarditis and cardiomyopathy associated with clozapine , 1999, The Lancet.

[15]  Takeo Takahashi,et al.  Hypokalemia and agitation in acute psychotic patients , 1999, Psychiatry Research.

[16]  A. Wilde,et al.  "Brugada" syndrome: clinical data and suggested pathophysiological mechanism. , 1999, Circulation.

[17]  J. Bigger,et al.  Cardiovascular effects of fluoxetine in depressed patients with heart disease. , 1998, The American journal of psychiatry.

[18]  G. Jennings,et al.  Panic disorder: coronary spasm as a basis for cardiac risk? , 1998, The Medical journal of Australia.

[19]  A. Glassman.  Cardiovascular effects of antidepressant drugs: updated , 1998, The Journal of clinical psychiatry.

[20]  B. Pollock,et al.  Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. , 1998, JAMA.

[21]  B. Pollock,et al.  Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease , 1997, Biological Psychiatry.

[22]  A. Malliani,et al.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .

[23]  K. Merikangas,et al.  Combination monoamine oxidase inhibitor and β-blocker treatment of migraine, with anxiety and depression , 1995, Biological Psychiatry.

[24]  J. L. Willems,et al.  The Diagnostic Performance of Computer Programs for the Interpretation of Electrocardiograms , 1991 .

[25]  H. Silver,et al.  Postural hypotension in chronically medicated schizophrenics. , 1990, The Journal of clinical psychiatry.

[26]  M. Lader,et al.  Cardiovascular effects of antidepressants , 1990, Psychological medicine. Monograph supplement.

[27]  J. Bigger,et al.  Tricyclic antidepressants in depressed patients with cardiac conduction disease. , 1987, Archives of general psychiatry.

[28]  J. Bigger,et al.  CLINICAL CHARACTERISTICS OF IMIPRAMINE-INDUCED ORTHOSTATIC HYPOTENSION , 1979, The Lancet.

[29]  G. Burrows,et al.  Cardiac Effects of Different Tricyclic Antidepressant Drugs , 1976, British Journal of Psychiatry.

[30]  John R. Hampton,et al.  The ECG Made Easy , 1973 .

[31]  M. Frank,et al.  Phenothiazine-induced T-wave abnormalities. Effects of overnight fasting. , 1973, JAMA.

[32]  M. Wendkos.  CARDIAC CHANGES RELATED TO PHENOTHIAZINE THERAPY, WITH SPECIAL REFERENCE TO THIORIDAZINE * , 1967, Journal of the American Geriatrics Society.

[33]  I. Khan.  Clinical and therapeutic aspects of congenital and acquired long QT syndrome. , 2002, The American journal of medicine.

[34]  PhD MD Chairman Writing Marek Malik.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996, Circulation.

[35]  Robert Lemery,et al.  Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. , 1992, The New England journal of medicine.